RenaissanceRe (NYSE:RNR) Price Target Raised to $319.00 at UBS Group

RenaissanceRe (NYSE:RNR) had its price objective increased by UBS Group from $312.00 to $319.00 in a research report sent to investors on Wednesday morning,Benzinga reports. UBS Group currently has a neutral rating on the insurance provider’s stock.

RNR has been the subject of several other research reports. Cantor Fitzgerald raised their target price on RenaissanceRe from $252.00 to $282.00 and gave the company a “neutral” rating in a research note on Wednesday, January 14th. JPMorgan Chase & Co. raised their target price on RenaissanceRe from $303.00 to $329.00 and gave the company a “neutral” rating in a research note on Wednesday, January 7th. TD Cowen upped their target price on RenaissanceRe from $280.00 to $290.00 and gave the company a “hold” rating in a report on Thursday, February 26th. Citigroup upped their target price on RenaissanceRe from $328.00 to $333.00 and gave the company a “neutral” rating in a report on Wednesday, February 18th. Finally, Barclays upped their target price on RenaissanceRe from $310.00 to $341.00 and gave the company an “equal weight” rating in a report on Wednesday. Two equities research analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $305.43.

RenaissanceRe Trading Up 1.5%

Shares of RNR stock opened at $307.25 on Wednesday. The stock has a 50-day simple moving average of $297.37 and a 200 day simple moving average of $275.97. RenaissanceRe has a fifty-two week low of $222.75 and a fifty-two week high of $315.88. The stock has a market capitalization of $13.26 billion, a P/E ratio of 5.42, a P/E/G ratio of 0.70 and a beta of 0.24. The company has a quick ratio of 1.43, a current ratio of 1.43 and a debt-to-equity ratio of 0.21.

RenaissanceRe (NYSE:RNR) last announced its earnings results on Tuesday, February 3rd. The insurance provider reported $13.34 earnings per share for the quarter, beating the consensus estimate of $10.59 by $2.75. RenaissanceRe had a return on equity of 18.29% and a net margin of 20.88%.The business had revenue of $2.97 billion during the quarter, compared to analysts’ expectations of $1.73 billion. During the same quarter last year, the business posted $8.06 earnings per share. The company’s quarterly revenue was up 29.6% on a year-over-year basis. On average, sell-side analysts expect that RenaissanceRe will post 26.04 earnings per share for the current fiscal year.

RenaissanceRe Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 31st. Stockholders of record on Friday, March 13th were issued a dividend of $0.41 per share. This is a positive change from RenaissanceRe’s previous quarterly dividend of $0.40. This represents a $1.64 annualized dividend and a dividend yield of 0.5%. The ex-dividend date of this dividend was Friday, March 13th. RenaissanceRe’s dividend payout ratio (DPR) is currently 2.89%.

Insider Activity at RenaissanceRe

In other news, EVP Robert Qutub sold 5,000 shares of the company’s stock in a transaction on Friday, February 6th. The stock was sold at an average price of $305.75, for a total transaction of $1,528,750.00. Following the completion of the sale, the executive vice president directly owned 73,023 shares of the company’s stock, valued at $22,326,782.25. This represents a 6.41% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. 1.30% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On RenaissanceRe

Several hedge funds have recently bought and sold shares of the business. SBI Securities Co. Ltd. lifted its stake in RenaissanceRe by 33.6% in the 4th quarter. SBI Securities Co. Ltd. now owns 147 shares of the insurance provider’s stock worth $41,000 after acquiring an additional 37 shares in the last quarter. MassMutual Private Wealth & Trust FSB lifted its stake in RenaissanceRe by 20.4% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 230 shares of the insurance provider’s stock worth $65,000 after acquiring an additional 39 shares in the last quarter. Exchange Traded Concepts LLC lifted its stake in RenaissanceRe by 1.2% in the 3rd quarter. Exchange Traded Concepts LLC now owns 3,355 shares of the insurance provider’s stock worth $852,000 after acquiring an additional 40 shares in the last quarter. AMG National Trust Bank lifted its stake in RenaissanceRe by 0.7% in the 3rd quarter. AMG National Trust Bank now owns 5,787 shares of the insurance provider’s stock worth $1,469,000 after acquiring an additional 40 shares in the last quarter. Finally, Beacon Pointe Advisors LLC lifted its stake in RenaissanceRe by 2.2% in the 4th quarter. Beacon Pointe Advisors LLC now owns 1,857 shares of the insurance provider’s stock worth $522,000 after acquiring an additional 40 shares in the last quarter. 99.97% of the stock is owned by hedge funds and other institutional investors.

Trending Headlines about RenaissanceRe

Here are the key news stories impacting RenaissanceRe this week:

• Positive Sentiment: Barclays raised its price target to $341 (from $310) and kept an “equal weight” rating — implying roughly an 11.0% upside from the current price, signaling stronger analyst confidence in RenaissanceRe’s outlook. Read More.
• Positive Sentiment: Keefe, Bruyette & Woods lifted its target to $327 (from $323) and maintained “market perform,” implying ~6.4% upside and reinforcing positive analyst revisions this week. Read More.
• Positive Sentiment: UBS increased its target to $319 (from $312) with a “neutral” rating, representing ~3.8% upside — another upward revision supporting the rally. Read More.
• Positive Sentiment: Zacks highlighted RNR among five P&C insurers positioned to benefit from digitalization and pricing strength following catastrophes — a thematic endorsement of sector tailwinds that could boost revenue and underwriting margins. Read More.
• Neutral Sentiment: Zacks published a deeper piece weighing RNR for value investors, focusing on earnings estimate trends and valuation — useful analysis but not a definitive buy/sell signal by itself. Read More.
• Neutral Sentiment: Aggregate broker coverage remains an average “Hold” per AmericanBankingNews, indicating overall market caution despite the recent target lifts. Read More.

About RenaissanceRe

RenaissanceRe Holdings Ltd. is a global provider of reinsurance and insurance solutions, specializing in property catastrophe, casualty, and specialty lines. Established in 1993 and headquartered in Bermuda, the company trades on the New York Stock Exchange under the symbol RNR. With a focus on underwriting and risk assessment, RenaissanceRe offers tailored programs designed to help insurers and corporations manage exposure to natural disasters, liability claims, and other complex risks.

The company operates through two primary segments: Reinsurance and Insurance.